Kevin Raymond Merrill Smith is CEO and President of Inogen Inc. Currently has a direct ownership of 70,274 shares of INGN, which is worth approximately $553,759. The most recent transaction as insider was on Mar 03, 2025, when has been sold 11,709 shares (Common Stock) at a price of $8.56 per share, resulting in proceeds of $100,229. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.3K
382.85% 3M change
n/a 12M change
Total Value Held $553,759

Kevin Raymond Merrill Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
BUY
Open market or private purchase
$100,229 $8.56 p/Share
11,709 Added 14.28%
70,274 Common Stock
Mar 01 2025
SELL
Payment of exercise price or tax liability
$331,509 $8.33 p/Share
39,797 Reduced 40.46%
58,565 Common Stock
Mar 01 2025
BUY
Exercise of conversion of derivative security
-
28,333 Added 38.96%
44,387 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
$231,330 $4.17 p/Share
55,475 Added 39.59%
84,662 Common Stock
Dec 01 2024
SELL
Payment of exercise price or tax liability
$133,794 $9.71 p/Share
13,779 Reduced 48.63%
14,554 Common Stock
Dec 01 2024
BUY
Exercise of conversion of derivative security
-
28,333 Added 50.0%
28,333 Common Stock

Also insider at

ONCS
ONCOSEC MEDICAL Inc Healthcare
KRM

Kevin Raymond Merrill Smith

CEO and President
Pennington, NJ

Track Institutional and Insider Activities on INGN

Follow Inogen Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INGN shares.

Notify only if

Insider Trading

Get notified when an Inogen Inc insider buys or sells INGN shares.

Notify only if

News

Receive news related to Inogen Inc

Track Activities on INGN